Massaro, Marika <br/><br/>
Dipyridamole decreases inflammatory metalloproteinase-9 expression and release by human monocytes.  [electronic resource] 

 -  Thrombosis and haemostasis  Feb 2013 
 - 280-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2567-689X 
<br/><br/><label>Standard No.: </label>10.1160/TH12-05-0326  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents--pharmacology<br/>Cyclic AMP--metabolism<br/>Cyclic GMP--metabolism<br/>Dipyridamole--pharmacology<br/>Dose-Response Relationship, Drug<br/>Down-Regulation<br/>Humans<br/>I-kappa B Proteins--metabolism<br/>Inflammation Mediators--metabolism<br/>Matrix Metalloproteinase 9--genetics<br/>Monocytes--drug effects<br/>NF-KappaB Inhibitor alpha<br/>RNA, Messenger--metabolism<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Tissue Inhibitor of Metalloproteinase-1--metabolism<br/>Transcription Factor AP-1--metabolism<br/>Transcription Factor RelA--metabolism<br/>Tumor Necrosis Factor-alpha--metabolism<br/>U937 Cells<br/>p38 Mitogen-Activated Protein Kinases--metabolism